1. Home
  2. EXEL vs TTAN Comparison

EXEL vs TTAN Comparison

Compare EXEL & TTAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EXEL
  • TTAN
  • Stock Information
  • Founded
  • EXEL 1994
  • TTAN 2012
  • Country
  • EXEL United States
  • TTAN United States
  • Employees
  • EXEL N/A
  • TTAN N/A
  • Industry
  • EXEL Biotechnology: Biological Products (No Diagnostic Substances)
  • TTAN
  • Sector
  • EXEL Health Care
  • TTAN
  • Exchange
  • EXEL Nasdaq
  • TTAN NYSE
  • Market Cap
  • EXEL 9.4B
  • TTAN 8.4B
  • IPO Year
  • EXEL 2000
  • TTAN 2024
  • Fundamental
  • Price
  • EXEL $37.42
  • TTAN $97.10
  • Analyst Decision
  • EXEL Buy
  • TTAN Buy
  • Analyst Count
  • EXEL 18
  • TTAN 13
  • Target Price
  • EXEL $37.59
  • TTAN $114.33
  • AVG Volume (30 Days)
  • EXEL 2.8M
  • TTAN 471.9K
  • Earning Date
  • EXEL 04-29-2025
  • TTAN 03-13-2025
  • Dividend Yield
  • EXEL N/A
  • TTAN N/A
  • EPS Growth
  • EXEL 170.77
  • TTAN N/A
  • EPS
  • EXEL 1.76
  • TTAN N/A
  • Revenue
  • EXEL $2,168,701,000.00
  • TTAN $771,878,000.00
  • Revenue This Year
  • EXEL $5.45
  • TTAN $16.97
  • Revenue Next Year
  • EXEL $10.32
  • TTAN $13.31
  • P/E Ratio
  • EXEL $21.43
  • TTAN N/A
  • Revenue Growth
  • EXEL 18.50
  • TTAN 25.64
  • 52 Week Low
  • EXEL $20.14
  • TTAN $79.81
  • 52 Week High
  • EXEL $40.02
  • TTAN $112.00
  • Technical
  • Relative Strength Index (RSI)
  • EXEL 58.85
  • TTAN N/A
  • Support Level
  • EXEL $36.68
  • TTAN N/A
  • Resistance Level
  • EXEL $37.99
  • TTAN N/A
  • Average True Range (ATR)
  • EXEL 1.09
  • TTAN 0.00
  • MACD
  • EXEL -0.11
  • TTAN 0.00
  • Stochastic Oscillator
  • EXEL 49.87
  • TTAN 0.00

About EXEL Exelixis Inc.

Exelixis is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its lead molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.

About TTAN SERVICETITAN INC

ServiceTitan Inc is an end-to-end technology platform built for contractors to transform the performance of their businesses. The Company's platform provides business owners, technicians, customer service representatives and other key office staff with technology tools designed to help customers grow revenue, drive operational efficiencies, deliver a superior end-customer experience and monitor key business drivers in real-time.

Share on Social Networks: